Evaluation of the COVID-19 Infection Response in Patients Admitted to the Emergency Department for Dyspnea

Emergencies Clinical Trial

— EPRICOD  

Official title:

Evaluation of the COVID-19 Infection Response in Patients Admitted to the Emergency Department for Dyspnea

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04422587
• Other study ID #: RC31/20/0149
• Status: Completed
• Start date: March 13, 2020
• Est. completion date: June 7, 2020

Study information

• Verified date: November 2020
• Source: University Hospital, Toulouse
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

This research aims to improve our knowledge of the epidemiology of patients consulting in the COvid-19 Possible REspiratory Units (RECOP unit). Indeed, the epidemic linked to COVID-19 affects France and impacts its health system. The reception of all intermediate patients will be on the Emergency Structures (SU). Indeed, the French healthcare system centralizes unscheduled urgent care on the ER. The aspecific respiratory symptomatology in "intermediate" patients indicates them all the more at an admission to SU or the diagnostic approach to respiratory difficulty may be carried out.

A central issue of this diagnostic strategy will be to be rapid, since the diagnosis will have to be made in the context of significant flows, with a need to quickly refer patients to the most suitable downstream service, while limiting the risk contamination of caregivers and vulnerable patients if a COVID-19 + patient is admitted to an unsuitable service. However, virological tests do not currently allow rapid results for COVID-19.

Research project of investigatory aims to develop a predictive model of the risk of being COVID-19 positive for patients admitted to the emergency room for acute dyspnea.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 1860
• Est. completion date: June 7, 2020
• Est. primary completion date: June 5, 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: 15 Years and older

Eligibility

Inclusion Criteria:

• All patients over 15 years admitted to the RECOP unit for dyspnea

Exclusion Criteria:

• Patient admitted to shock for respiratory distress requiring immediate respiratory support.

• Patient under justice safeguard

Related Conditions & MeSH terms

• Dyspnea
• Emergencies

Intervention

Other:
• RECOP unit patient
All patients admit in RECOP unit for dyspnea can be included in this study if patient is agree. Then, doctor collects demographic variables, the usual history and treatments, the characteristics of the episode (symptomatology, evolution, treatment taken) and the data from the initial clinical examination will be identified.

Locations

Country	Name	City	State
France	University Hospital of Toulouse	Toulouse

Sponsors (1)

Lead Sponsor	Collaborator
University Hospital, Toulouse

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Develop a predictive model of the risk of being COVID-19 for patients admitted to the emergency room for dyspnea	demographic variables, usual history and treatments, episode characteristics (symptomatology, evolution, treatment taken) and data from the initial clinical examination will be collected by doctor	inclusion day
Secondary	Describe the characteristics of patients admitted to reCOP units according to their virological status	The COVID-19 virological condition will be taken with PCR tests on naso-pharyngeal samples or on sputum for patients taking	30 days
Secondary	Virological status	Virological status will be collected by a phone call at the patient	30 days
Secondary	Mortality status	Mortality status will be collected by a phone call at the patient	30 days